ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Balance Sheet
NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 53.10M | 71.33M | 88.40M | 53.60M | 96.40M | |||
| Marketable Securities | 144.98M | 156.62M | 183.46M | 355.90M | 290.60M | |||
| Receivables | 85.42M | 73.07M | 25.81M | 8.50M | 400.00K | |||
| Inventories | 16.61M | 14.53M | 13.13M | 7.50M | N/A | |||
| Other Current Assets | 23.55M | 20.27M | 19.63M | 11.80M | 15.30M | |||
| Total Current Assets | 323.67M | 335.82M | 330.43M | 437.40M | 402.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.34M | 2.99M | 3.90M | 4.60M | 5.30M | |||
| Intangibles | 16.50M | 9.48M | 6.44M | 7.20M | N/A | |||
| Other Non-Current Assets | 596.00K | 596.00K | 596.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 20.43M | 13.07M | 10.93M | 11.90M | 5.40M | |||
| TOTAL ASSETS | 344.11M | 348.89M | 341.37M | 449.30M | 408.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 66.60M | 66.79M | 34.68M | 29.00M | 26.00M | |||
| Accounts Payable | 24.53M | 14.22M | 11.99M | 8.80M | 7.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 91.13M | 81.01M | 46.67M | 37.80M | 33.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 107.62M | 107.20M | 201.80M | 197.80M | 72.40M | |||
| Other Non-Current Liabilities | 2.70M | 3.13M | 4.23M | 4.10M | 4.80M | |||
| Total Non-Current Liabilities | 110.32M | 110.33M | 206.03M | 201.90M | 77.20M | |||
| TOTAL LIABILITIES | 201.45M | 191.35M | 252.70M | 239.70M | 110.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.15B | -1.12B | -981.90M | -719.80M | -408.30M | |||
| Additional Paid In Capital | 1.29B | 1.28B | 1.07B | 930.40M | 706.20M | |||
| Common Shares | 12.00K | 12.00K | 9.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -140.00K | -7.00K | 4.00K | -1.10M | -300.00K | |||
| Shares Outstanding | 119.14M | 117.85M | 96.79M | 61.00M | 50.30M | |||
| Tangible Book Value per Share | 1.06 | 1.26 | 0.85 | 3.32 | 5.92 | |||
| Total Shareholders' Equity | 142.66M | 157.54M | 88.67M | 209.60M | 297.70M | |||
| TOTAL LIABILITIES AND EQUITY | 344.11M | 348.89M | 341.37M | 449.30M | 408.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.75 | 0.68 | 2.28 | 0.94 | 0.24 | |||
| Current Ratio | 3.55 | 4.15 | 7.08 | 11.57 | 12.10 | |||
| Return On Assets (ROA) | -37.70% | -40.14% | -76.79% | -69.32% | -50.55% | |||
| Return On Equity (ROE) | -90.93% | -88.89% | -295.65% | -148.60% | -69.32% | |||
All data in USD , ROIC based on taxRate of 0.21